Goldman Sachs’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $79.2M | Sell |
2,153,397
-11,104
| -0.5% | -$409K | 0.01% | 892 |
|
|
2025
Q1 | $76.5M | Sell |
2,164,501
-465,651
| -18% | -$16.5M | 0.01% | 809 |
|
|
2024
Q4 | $115M | Buy |
2,630,152
+275,550
| +12% | +$12.1M | 0.02% | 614 |
|
|
2024
Q3 | $107M | Buy |
2,354,602
+906,507
| +63% | +$41.1M | 0.02% | 650 |
|
|
2024
Q2 | $56.2M | Buy |
1,448,095
+324,645
| +29% | +$12.6M | 0.01% | 935 |
|
|
2024
Q1 | $36.2M | Buy |
1,123,450
+70,193
| +7% | +$2.26M | 0.01% | 1167 |
|
|
2023
Q4 | $30.2M | Buy |
1,053,257
+425,812
| +68% | +$12.2M | 0.01% | 1278 |
|
|
2023
Q3 | $17.4M | Sell |
627,445
-70,234
| -10% | -$1.94M | ﹤0.01% | 1613 |
|
|
2023
Q2 | $18.7M | Sell |
697,679
-438,379
| -39% | -$11.7M | ﹤0.01% | 1606 |
|
|
2023
Q1 | $24.6M | Buy |
1,136,058
+134,841
| +13% | +$2.92M | 0.01% | 1361 |
|
|
2022
Q4 | $23.8M | Sell |
1,001,217
-39,209
| -4% | -$934K | 0.01% | 1469 |
|
|
2022
Q3 | $20.5M | Buy |
1,040,426
+150,929
| +17% | +$2.98M | 0.01% | 1577 |
|
|
2022
Q2 | $17.3M | Buy |
889,497
+19,990
| +2% | +$390K | ﹤0.01% | 1719 |
|
|
2022
Q1 | $22.2M | Buy |
869,507
+175,304
| +25% | +$4.47M | ﹤0.01% | 1647 |
|
|
2021
Q4 | $17.5M | Sell |
694,203
-279,695
| -29% | -$7.04M | ﹤0.01% | 1857 |
|
|
2021
Q3 | $26.8M | Buy |
973,898
+269,641
| +38% | +$7.42M | 0.01% | 1510 |
|
|
2021
Q2 | $22.4M | Sell |
704,257
-2,434
| -0.3% | -$77.3K | 0.01% | 1660 |
|
|
2021
Q1 | $32.4M | Buy |
706,691
+199,625
| +39% | +$9.16M | 0.01% | 1325 |
|
|
2020
Q4 | $20.1M | Buy |
507,066
+453,272
| +843% | +$17.9M | 0.01% | 1557 |
|
|
2020
Q3 | $1.87M | Sell |
53,794
-75,056
| -58% | -$2.61M | ﹤0.01% | 2945 |
|
|
2020
Q2 | $4.07M | Buy |
128,850
+63,162
| +96% | +$1.99M | ﹤0.01% | 2455 |
|
|
2020
Q1 | $1.44M | Buy |
+65,688
| New | +$1.44M | ﹤0.01% | 2926 |
|